Agreement - March 12, 2014
Orexo enters agreement for Zubsolv
Orexo AB has announced a multi-year agreement with UnitedHealth Group and OptumRx providing preferred coverage and reimbursement of Zubsolv. Zubsolv is a sublingual tablet formulation for maintenance treatment of opioid dependence. Under the agreement, the product will be given preferred, Tier 2 brand status on UnitedHealth Group commercial employer and individual formularies managed by OptumRx for […]
Agreement - March 12, 2014
Biogaia enters extended agreement with Nestlé
Nestlé and BioGaia have entered into a supplementary agreement to the original from February 2012 when Biogaia sold the rights for the use of Lactobacillus reuteri Protectis in infant formula to Nestle. Under the original agreement in 2012, Biogaia received EUR 40 million up-front as well as a commitment to a further EUR 10.8 million between […]
Agreement - February 28, 2014
Spain participates in the building of ESS
Spain will contribute with EUR 90 million in the building of the European Spallation Source in Lund, south of Sweden. Sweden and Spain reached an agreement recently that Spain will contribute to the building of ESS with 5 percent, according to a statement from the Government Offices of Sweden. The total cost for ESS is […]
Agreement - February 26, 2014
Saniona collaborates with Pfizer in million dollar agreement
The Danish biotechnology company has announced a drug developement collaboration with the global pharma giant. Saniona, previously known under the name Aniona, focuses on small molecule drug discovery within the ion channel field. The collaboration with Pfizer involves research on pharmaceuticals to treat neurological diseases and makes use of Saniona’s expertise within the ion channel field, […]
Agreement - February 24, 2014
Dilafor in new license agreement
Dilafor AB, part of Karolinska Development’s portfolio of companies, has signed an agreement with Hong Kong-based biopharmaceutical firm. According to the agreement, Dilafor grants to Lee’s Pharmaceutical the right to manufacture, develop and commercialize tafoxiparin for obstetrics and gynecological indications in China, Hong Kong, Macau and Taiwan. Pursuant to the terms of the agreement, Dilafor and Lee’s […]
Agreement - February 21, 2014
Mendor collaborates with Chinese distributor
The Finnish diabetes technology company has signed an exclusive distribution agreement for its blood glucose meter with Beijing Tagene Medical Co., Ltd. Under the agreement, Tagene will distribute the all-in-one blood glucose meter Mendor Discreet throughout China as of May this year for Mendor Discreet to be available to Chinese diabetes patients. “This is great news as we have worked hard […]
